These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33926982)

  • 1. Cost-effectiveness of emergency preparedness measures in response to infectious respiratory disease outbreaks: a systematic review and econometric analysis.
    Vardavas C; Nikitara K; Zisis K; Athanasakis K; Phalkey R; Leonardi-Bee J; Johnson H; Tsolova S; Ciotti M; Suk JE
    BMJ Open; 2021 Apr; 11(4):e045113. PubMed ID: 33926982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU/UK/OECD: a systematic review.
    Vardavas C; Zisis K; Nikitara K; Lagou I; Marou V; Aslanoglou K; Athanasakis K; Phalkey R; Leonardi-Bee J; Fernandez E; Condell O; Lamb F; Sandmann F; Pharris A; Deogan C; Suk JE
    BMJ Open; 2023 Oct; 13(10):e077602. PubMed ID: 37907290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Considerations in Infectious Diseases Emergency Response Preparedness: It's All About the Point of View.
    Branch-Elliman W; Safdar N; Nelson R
    Clin Infect Dis; 2021 Jan; 72(1):148-152. PubMed ID: 32379858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Influencing the Response to Infectious Diseases: Focusing on the Case of SARS and MERS in South Korea.
    Lee KM; Jung K
    Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 31013648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola virus outbreak preparedness plan for developing Nations: Lessons learnt from affected countries.
    Gupta S; Gupta N; Yadav P; Patil D
    J Infect Public Health; 2021 Mar; 14(3):293-305. PubMed ID: 33610938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency.
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Pharmacoeconomics; 2005; 23(4):395-420. PubMed ID: 15853438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Effectiveness of Public Health Measures During Infectious Disease Outbreaks: A Systematic Review.
    Lawrence A
    Cureus; 2024 Mar; 16(3):e55893. PubMed ID: 38595888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
    Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?
    Anopa Y; Conway DI
    Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.
    Cranny G; Elliott R; Weatherly H; Chambers D; Hawkins N; Myers L; Sculpher M; Eastwood A
    Health Technol Assess; 2008 Jan; 12(1):iii-iv, xi-xii, 1-147. PubMed ID: 18093447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic impacts of airborne and droplet-borne infectious diseases on industries: a systematic review.
    Samsudin EZ; Yasin SM; Ruslan NH; Abdullah NN; Noor AFA; Hair AFA
    BMC Infect Dis; 2024 Jan; 24(1):93. PubMed ID: 38229063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived Facilitators and Barriers to Local Health Department Workers' Participation in Infectious Disease Emergency Responses.
    Rutkow L; Paul A; Taylor HA; Barnett DJ
    J Public Health Manag Pract; 2017; 23(6):644-650. PubMed ID: 28832434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement.
    Whitaker R; Hendry M; Aslam R; Booth A; Carter B; Charles JM; Craine N; Tudor Edwards R; Noyes J; Ives Ntambwe L; Pasterfield D; Rycroft-Malone J; Williams N
    Health Technol Assess; 2016 Feb; 20(16):1-214. PubMed ID: 26931051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.
    Davies L; Brown TJ; Haynes S; Payne K; Elliott RA; McCollum C
    Health Technol Assess; 2006 Nov; 10(44):iii-iv, ix-x, 1-210. PubMed ID: 17049141
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.